Manufacture of bulk drugs at the heart of what we do
India’s first company to start commercial production of Anti-tuberculosis drug Rifampicin
Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with GIIC Ltd. and Chemosyn (P) Ltd. It commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007.
News Corner
2026-08-26 12:29:04 - Preliminary Placement Document
2026-08-24 20:09:57 - Proceedings of E.G.M held on 22.08.2026
2026-06-30 16:08:42 - Investors Presentation dated 29th June, 2026
2026-06-25 23:39:00 - Intimation of Closure of Trading Window for the quarter ending 30th June, 2026
2026-04-10 16:19:38 - Newspaper Publication titled “Notice with respect to Special Window for re-lodgement of transfer requests and dematerialisation of physical shares
Annual Report 2024 – 2025